XML 25 R12.htm IDEA: XBRL DOCUMENT v3.25.4
Cash, Cash Equivalents and Short-term Investments
6 Months Ended
Dec. 27, 2025
Cash and Cash Equivalents [Abstract]  
Cash, Cash Equivalents and Short-term Investments
Note 5. Cash, Cash Equivalents and Short-term Investments
The following table summarizes our cash, cash equivalents and short-term investments by category for the periods presented (in millions):
Amortized
Cost
 Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
December 27, 2025:
Cash$460.1 $— $— $460.1 
Cash equivalents:
Certificates of deposit31.3 — — 31.3 
Money market funds74.6 — — 74.6 
U.S. Treasury securities91.7 — — 91.7 
Total cash and cash equivalents$657.7 $— $— $657.7 
Short-term investments:
Commercial paper24.6 — — 24.6 
Corporate debt securities275.3 0.8 (0.1)276.0 
U.S. Agency securities137.0 0.2 — 137.2 
U.S. Treasury securities59.6 0.2 — 59.8 
Total short-term investments$496.5 $1.2 $(0.1)$497.6 
June 28, 2025:
Cash$349.5 $— $— $349.5 
Cash equivalents:
Commercial paper2.5 — — 2.5 
Money market funds161.7 — — 161.7 
U.S. Treasury securities7.0 — — 7.0 
Total cash and cash equivalents$520.7 $— $— $520.7 
Short-term investments:
Commercial paper$2.7 $— $— $2.7 
Corporate debt securities210.9 0.3 (0.1)211.1 
U.S. Agency securities67.6 0.1 — 67.7 
U.S. Treasury securities74.8 0.1 — 74.9 
Total short-term investments$356.0 $0.5 $(0.1)$356.4 
We review our investment portfolio to identify and evaluate investments that have indicators of possible impairment. Factors considered in determining whether a loss is other-than-temporary include, but are not limited to, the length of time and extent a security’s fair value has been below its cost, the financial condition and near-term prospects of the investee, the credit quality of the security’s issuer, likelihood of recovery and our intent and ability to hold the security for a period sufficient to allow for any anticipated recovery in value. For the debt instruments we own, we also evaluate whether we have the intent to sell the security or whether it is more likely than not that we will be required to sell the security before recovery of its cost basis. We have not recorded our unrealized losses on our short-term investments into our results of operations because we do not intend to sell nor is it more likely than not that we will be required to sell these investments prior to recovery of their amortized cost basis.
We use the specific-identification method to determine any realized gains or losses from the sale of our short-term investments classified as available-for-sale. During the three and six months ended December 27, 2025, we did not realize significant gains or losses on a gross level from the sale of our short-term investments classified as available-for-sale.
During the three and six months ended December 27, 2025, our other income, net was $11.0 million and $15.2 million, respectively, which includes interest and investment income on cash equivalents and short-term investments of $11.6 million and $20.2 million, respectively.
During the three and six months ended December 28, 2024, our other income, net was $14.9 million and $23.6 million, respectively, which includes interest and investment income on cash equivalents and short-term investments of $9.0 million and $18.4 million, respectively.
As of December 27, 2025 and June 28, 2025, we recorded interest receivables of $6.3 million and $5.2 million, respectively, included in prepayments and other current assets within the condensed consolidated balance sheets. We did not recognize an allowance for credit losses against interest receivables in any of the periods presented.
The following table summarizes unrealized losses on our cash equivalents and short-term investments by category that have been in a continuous unrealized loss position for more than 12 months and less than 12 months as of the periods presented, respectively (in millions):
Continuous Loss Position for
 More Than 12 Months
Continuous Loss Position for
 Less Than 12 Months
Gross Unrealized Losses
Fair ValueUnrealized LossesFair ValueUnrealized Losses
December 27, 2025:
U.S. Agency securities$— $— $68.4 $— $— 
Commercial paper— — 9.9 — — 
Corporate debt securities1.0 — 69.2 (0.1)(0.1)
U.S. government bonds— — 3.5 — — 
Total $1.0 $— $151.0 $(0.1)$(0.1)
June 28, 2025:
U.S. Agency securities$— $— $24.5 $— $— 
Commercial paper— — 5.2 — — 
Corporate debt securities— — 73.8 (0.1)(0.1)
U.S. government bonds— — 35.3 — — 
Total$— $— $138.8 $(0.1)$(0.1)
The following table classifies our short-term investments by remaining maturities (in millions): 
December 27, 2025June 28, 2025
Amortized CostFair ValueAmortized CostFair Value
Due within 1 year$171.7 $171.9 $139.9 $140.0 
Due in 1 year to 5 years324.8 325.7 216.1 216.4 
Total$496.5 $497.6 $356.0 $356.4 
All available-for-sale securities have been classified as current, based on management’s intent and ability to use the funds in current operations.